Nan Fung Group Holdings Ltd reported 25 holdings worth US$131M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 13, 2026
Nan Fung Group Holdings Ltd reported 25 holdings worth US$131M as of Jun 30, 2026. Largest: Maplight Therapeutics, Inc., Lb Pharmaceuticals Inc and Evommune, Inc. Filed Aug 13, 2026 (Form 13F).
- Holdings
- 25
- Value as reported
- US$131M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Maplight Therapeutics, Inc. | 971K | US$34.8M | 26.5% |
| Lb Pharmaceuticals Inc | 631K | US$20.5M | 15.6% |
| Evommune, Inc. | 1.44M | US$19.2M | 14.6% |
| Cybin, Inc. | 987K | US$6.53M | 5.0% |
| Incyte Corporation | 53,742 | US$6.09M | 4.6% |
| Rhythm Pharmaceuticals, Inc. | 49,120 | US$5.45M | 4.1% |
| Beone Medicines Ltd. Class A | 15,722 | US$4.48M | 3.4% |
| Revolution Medicines, Inc. | 19,253 | US$3.61M | 2.7% |
| Kymera Therapeutics, Inc. | 30,875 | US$3.54M | 2.7% |
| Madrigal Pharmaceuticals, Inc. | 5,672 | US$3.05M | 2.3% |
| Celcuity Inc. | 28,300 | US$2.96M | 2.3% |
| Acadia Pharmaceuticals Inc. | 103K | US$2.61M | 2.0% |
| Argenx Se | 2,800 | US$2.6M | 2.0% |
| Recursion Pharmaceuticals, Inc. | 595K | US$2.18M | 1.7% |
| Procore Technologies, Inc. | 53,299 | US$2.17M | 1.6% |
| Harmony Biosciences Holdings, Inc. | 27,049 | US$985K | 0.75% |
| Insmed Incorporated | 6,580 | US$702K | 0.53% |
| Chime Financial, Inc. | 21,075 | US$432K | 0.33% |
| Rani Therapeutics Holdings, Inc. | 494K | US$375K | 0.29% |
| Entrada Therapeutics, Inc. | 49,082 | US$361K | 0.27% |
| Bolt Biotherapeutics, Inc. | 5,000 | US$19,250 | 0.01% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |